In addition, although Sema3E in embryonic somites is known to repel Plexin-D1-expressing endothelial cells during vasculogenesis, both anti-angiogenic and pro-angiogenic effects of Sema3E have been reported in cancer cells. The gene discussed is SEMA3E; the disease is cancer.